Orris

Treatment of esophageal candidiasis

Reading File
Searching for treatment of esophageal candidiasis across antifungal therapy and management guidelines.
search_medical_text

esophageal candidiasis treatment antifungal therapy

Management of Candidiasis

Page 38

search_medical_text

fluconazole resistant esophageal candidiasis management HIV immunocompromised

Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV

Page 57

GradeResponse
GradeResponse
Esophageal candidiasis treatment (standard approach)
  1. First-line
    • Fluconazole PO 200 to 400 mg once daily for 14 to 21 days
      (Management of Candidiasis, p. 38)
  2. If unable to take oral meds
    • Fluconazole IV 400 mg daily, or
    • Echinocandin:
      • Micafungin 150 mg daily, or
      • Caspofungin 70 mg loading dose then 50 mg daily, or
      • Anidulafungin 200 mg daily
        (Management of Candidiasis, p. 38)
  3. If fluconazole-refractory disease
    • Itraconazole solution 200 mg daily or
    • Voriconazole 200 mg twice daily (PO or IV) for 14 to 21 days
      Alternatives:
    • Echinocandin for 14 to 21 days, or
    • Amphotericin B deoxycholate 0.3 to 0.7 mg/kg daily (typically 21 days), or
    • Posaconazole (less strong evidence)
      (Management of Candidiasis, p. 38)
  4. Recurrent esophageal candidiasis
    • Suppressive fluconazole 100 to 200 mg three times weekly
      (Management of Candidiasis, p. 38)
Useful clinical points
  • Systemic therapy is required for esophageal disease (topical agents alone are not adequate).
  • In many patients with classic odynophagia/dysphagia and risk factors, an empiric antifungal trial can be started before endoscopy.
  • If symptoms fail to improve, consider resistant Candida species (for example, C. glabrata, C. krusei) and alternative causes of esophagitis such as HSV or CMV, especially in immunocompromised patients.
    (Management of Candidiasis, p. 38; OI in Children with HIV, p. 57)
If you want, I can give a quick regimen table tailored to a specific patient type (HIV, transplant, steroid use, pregnancy, renal/hepatic impairment).

l-ornithine l-aspartate Inj dose

Typical adult dosing for L-ornithine L-aspartate (LOLA) injection (used for hepatic encephalopathy/hyperammonemia) is:
  • 20 g/day IV infusion (often as 4 ampoules if each is 5 g/10 mL), diluted in IV fluid and infused over 4 to 6 hours.
  • In more severe cases, up to 40 g/day IV may be used in divided/continuous infusion depending on protocol.
Common practical method:
  • Add LOLA to 500 mL NS or D5W and infuse slowly.
  • Do not give as rapid IV bolus.
Dose varies by brand concentration and liver disease severity, so check the exact ampoule strength and hospital protocol.
If you share the brand/strength (for example, g per ampoule), I can calculate the exact mL and infusion rate.
This is a shared conversation. Sign in to Orris to start your own chat.